Published in Eur Addict Res on April 22, 2009
Risk of myocardial infarction immediately after alcohol consumption. Epidemiology (2015) 1.43
Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation (2011) 1.20
Risk of injury due to alcohol: evaluating potential bias using the case-crossover usual-frequency method. Epidemiology (2013) 1.01
Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis. Circulation (2016) 0.81
Can intensive use of alcohol-based hand rubs lead to passive alcoholization? Int J Environ Res Public Health (2010) 0.81
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health (2016) 0.78
Alcohol as a trigger for medical emergencies. Subst Use Misuse (2013) 0.77
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem (1999) 6.59
The 5' terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is required for the splicing of messenger RNA precursors. Cell (1984) 6.25
Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet (1999) 5.02
Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59
Interventions to reduce harm associated with adolescent substance use. Lancet (2007) 3.98
Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med (1996) 3.80
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
Generation of histone mRNA 3' ends by endonucleolytic cleavage of the pre-mRNA in a snRNP-dependent in vitro reaction. EMBO J (1986) 3.45
Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation (2001) 3.38
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med (2000) 3.09
Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction (1999) 3.00
Acute heart transplant rejection due to Saint John's wort. Lancet (2000) 2.71
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation (1994) 2.69
Characteristics of binge drinkers in Europe. Soc Sci Med (2004) 2.63
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation (1997) 2.51
The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together. Drug Alcohol Depend (2010) 2.37
Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science (2001) 2.35
Pet birds as an independent risk factor for lung cancer: case-control study. BMJ (1992) 2.34
Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med (1991) 2.34
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension (1986) 2.30
Heat-labile regulatory factor is required for 3' processing of histone precursor mRNAs. Proc Natl Acad Sci U S A (1987) 2.28
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation (1998) 2.27
Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9. Science (1993) 2.27
Social costs of untreated opioid dependence. J Urban Health (2000) 2.18
Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. RNA (1996) 2.16
N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Eur J Clin Invest (2007) 2.06
Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation (1996) 2.05
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Separation of splicing factor SF3 into two components and purification of SF3a activity. J Biol Chem (1993) 2.00
Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health (1999) 1.99
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 1.98
An overview of illegal opioid use and health services utilization in Canada. Public Health (2006) 1.97
Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation (1991) 1.96
Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation (2000) 1.93
Aggregate time-series regression in the field of alcohol. Addiction (2001) 1.92
Clinical assessment compared with breathalyser readings in the emergency room: concordance of ICD-10 Y90 and Y91 codes. Emerg Med J (2005) 1.87
The case for a heroin substitution treatment trial in Canada. Can J Public Health (1998) 1.86
Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J (2004) 1.76
Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed) (1987) 1.75
Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res (2001) 1.73
Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program. J Nerv Ment Dis (1996) 1.70
The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada. CMAJ (2000) 1.68
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
Different small nuclear ribonucleoprotein particles are involved in different steps of splicing complex formation. Cold Spring Harb Symp Quant Biol (1987) 1.67
Relation between average alcohol consumption and disease: an overview. Eur Addict Res (2001) 1.62
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest (1998) 1.62
Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol (1998) 1.58
Purification of a protein required for the splicing of pre-mRNA and its separation from the lariat debranching enzyme. EMBO J (1985) 1.56
Privatizing alcohol sales and alcohol consumption: evidence and implications. Addiction (1999) 1.54
The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction (1998) 1.53
High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J (2004) 1.53
Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time. CMAJ (2000) 1.52
Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest (1996) 1.50
Moderate drinking and health. Implications of recent evidence. Can Fam Physician (1997) 1.50
Systemic vascular effects of isoflurane versus propofol anesthesia in dogs. Anesth Analg (1996) 1.48
Sexual behavior and the prevalence of Chlamydia trachomatis infection in asymptomatic students in Germany and Spain. Eur J Epidemiol (2001) 1.48
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension (1990) 1.47
Predictors of long-term survival after valve replacement for chronic aortic regurgitation; is M-mode echocardiography sufficient? Eur Heart J (2001) 1.47
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A (2000) 1.47
Endothelin. Key to coronary vasospasm? Circulation (1991) 1.46
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart (2007) 1.45
Aging, serum estradiol levels, and pregnancy differentially affect vascular reactivity of the rat uterine artery. J Soc Gynecol Investig (2000) 1.44
Low-risk drinking guidelines: the scientific evidence. Can J Public Health (1999) 1.43
Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant (1994) 1.43
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 1.43
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation (1990) 1.42
Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. I. Motor reactions. Anesthesiology (1994) 1.41
Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension (1997) 1.41
Is blood pressure response to the Valsalva maneuver related to neurohormones, exercise capacity, and clinical findings in heart failure? Chest (1999) 1.40
Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.40
Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res (1999) 1.39
Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Can J Public Health (2001) 1.39
[Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions]. Schweiz Med Wochenschr (1997) 1.39
Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ (1993) 1.39
Brief report: reuse of a transplanted heart. N Engl J Med (1993) 1.38
Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow. Bone Marrow Transplant (1997) 1.38
Prevalence of tracheostomy in ICU patients. A nation-wide survey in Switzerland. Intensive Care Med (2000) 1.37
Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect (2010) 1.36
Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet (1999) 1.36
Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res (2001) 1.36
Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation (2000) 1.35
Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest (1995) 1.34
Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension (1995) 1.34
Monoclonal antibody directed against RNA polymerase II of Drosophila melanogaster. Mol Gen Genet (1980) 1.33
Nifedipine for high altitude pulmonary oedema. Lancet (1989) 1.32
The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol (1995) 1.32
Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol (2012) 1.31
Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension (1987) 1.30
Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol (1990) 1.28
Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly. EMBO J (1999) 1.27